Qube Research & Technologies LTD Clear Point Neuro, Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 163,014 shares of CLPT stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,014
Previous 234,488
30.48%
Holding current value
$2.14 Million
Previous $3.61 Million
46.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.28MShares$16.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$9.71 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$6.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.8 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$4.34 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $321M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...